Doctor profile · Federal record
Dr. Christopher Vandelune, D.O.
Family Medicine Physician (CMS: Family Practice) · Cherokee, IA
- NPI 1871598557
- Accepts Medicare
- MIPS 75.0 / 100 · 2023
- 25 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
115 E Maple St
Cherokee, IA 510121814
(712) 225-9003
fax (712) 225-9004
Credentials & registration
- NPI registered
- June 2005 — 21 yrs on file
- Profile last updated
- November 14, 2019
- Year of graduation
- 2001 — 25 yrs since
- Specialty taxonomy
- 207Q00000X — NUCC code
- State license (1)
- Iowa #03566
- Medicaid
- IA #0438754
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1871598557. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
6,254
Distinct HCPCS
10
Medicare allowed
$289,747
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0897 |
Injection, denosumab, 1 mg | 2,226 | 23 | $23 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 1,027 | 351 | $119 | |
36415 |
Insertion of needle into vein for collection of blood sample | 762 | 329 | $8 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 532 | 226 | $84 | |
G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 247 | 247 | $120 | |
G0444 |
Annual depression screening, 5 to 15 minutes | 222 | 222 | $17 | |
83036 |
Hemoglobin a1c level | 194 | 87 | $9 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 157 | 41 | $0 | |
17000 |
Destruction of precancer skin growth, 1 growth | 138 | 91 | $62 | |
J1040 |
Injection, methylprednisolone acetate, 80 mg | 101 | 50 | $12 |
In context: peer comparison
Among 2 peers in Cherokee Family Medicine Physician, average services per provider: 225. This provider delivers 28× the peer median.Open Payments
Industry payments received
All-time total
$666
Transactions
39
Manufacturers
12
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novo Nordisk INC | 10 | $175.15 | |
| Amgen INC. | 6 | $105.68 | |
| Xeris Pharmaceuticals, INC. | 5 | $83.10 | |
| AstraZeneca Pharmaceuticals Lp | 3 | $52.25 | |
| Abbvie INC. | 2 | $49.62 | |
| GlaxoSmithKline, LLC. | 3 | $44.00 | |
| Pfizer INC. | 3 | $43.90 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | 2 | $36.86 | |
| Bayer Healthcare Pharmaceuticals INC. | 2 | $30.30 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | 1 | $16.24 | |
| Astellas Pharma US INC | 1 | $14.70 | |
| Lilly USA, LLC | 1 | $13.75 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
4,948
Patients
1,087
Total drug cost
$166,811
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Atorvastatin Calcium | Generic | 619 | 140 | $7,249 |
| Amlodipine Besylate | Generic | 494 | 112 | $3,946 |
| Levothyroxine Sodium | Generic | 469 | 104 | $6,058 |
| Omeprazole | Generic | 443 | 104 | $4,734 |
| Losartan Potassium | Generic | 441 | 107 | $5,321 |
| Furosemide | Generic | 320 | 63 | $1,533 |
| Gabapentin | Generic | 315 | 67 | $4,661 |
| Lisinopril | Generic | 285 | 63 | $2,397 |
| Pantoprazole Sodium | Generic | 280 | 69 | $3,414 |
| Sertraline Hcl | Generic | 251 | 49 | $2,274 |
Frequently asked questions
What is Dr. Christopher Vandelune's medical specialty?
Dr. Christopher Vandelune practices Family Medicine Physician in Cherokee, IA.
Where does Dr. Christopher Vandelune practice?
Dr. Christopher Vandelune practices at 115 E Maple St, Cherokee, IA 510121814. Office phone: 7122259003.
What is Dr. Christopher Vandelune's NPI?
Dr. Christopher Vandelune's National Provider Identifier (NPI) is 1871598557, issued by NPPES.
Does Dr. Christopher Vandelune accept Medicare assignment?
Yes. Dr. Christopher Vandelune accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Christopher Vandelune commonly perform?
Top Medicare-reported procedures in 2023: Injection, denosumab, 1 mg (HCPCS J0897); Established patient office or other outpatient visit (HCPCS 99214); Insertion of needle into vein for collection of blood sample (HCPCS 36415). Source: CMS Medicare Physician & Other Practitioners file.